Rivaroxaban GeneriNobel

Medicinal product

(Invented) name

Rivaroxaban GeneriNobel

Active substance (s)

Rivaroksabanas+Rivaroksabanas

Strength

15 mg + 20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AF01, Rivaroxaban

Marketing authorisation holder

GeneriNobel GmbH, Vokietija

Date of authorisation

2026-08-31

Date of renewal

Documents

6136-40 Rivaroxaban GeneriNobel.docx

6140_pakuotes lapelis_2026-08-31.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/7121/005/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje (15 mg) yra	1 vnt.
Rivaroksabanas	15 mg
Tabletėje (20 mg) yra	1 vnt.
Rivaroksabanas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122244	108356	1108356	lizdinė plokštelė	N49 (42×15 mg+7×20 mg)		Receptinis	LT/1/26/6140/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-08-31	Registruotas